armacy chains, hospitals, payers, pharmacy benefit manager, health maintenance organizations, home healthcare, long-term care, and patients. Additionally, Mylan Specialty supports educational programs to consumers, physicians, and patients. The company’s major customers included AmeriSourceBergen Corporation, McKesson Corporation, and Cardinal Health, Inc. during the year ended December 31, 2015. Research and Development The company’s research and development spending was $672 million for the year ended December 31, 2015. Seasonality Certain parts of the company’s business are affected by seasonality, including products in its Specialty segment and products within the company’s Europe and Rest of World regions within its Generics segment. Government Regulation In Japan, the company is governed by various laws and regulations, including the Pharmaceutical Affairs Law (Law No. 145, 1960), as amended by the Pharmaceuticals and Medical Devices Law; and the Products Liability Law (Law No. 85, 1994). History Mylan N.V. was founded in 1961.
mylan nv (MYL:NASDAQ GS)
Hertfordshire, AL10 9UL
Phone: 44 1707 853000
Fax: 44 1707 261803www.mylan.com
The information and data displayed in this profile are created and managed by Capital IQ, a Standard & Poor's company. Bloomberg.com does not create or control the content.
|No competitor information is available for MYL.|
|View Industry Companies|
Sponsored Financial Commentaries
Only a company representative may request an update for the company profile. Documentation will be required.
To contact MYLAN NV, please visit www.mylan.com. Company data is provided by Capital IQ. Please use this form to report any data issues.